|
Tests
|
Reference
|
Median
|
Range
|
HR
|
p value
|
|---|
|
HCT (%)
|
41–53
|
37.80
|
30.70 – 44.6
|
1.03
|
0.73
|
|
Hgb (g/dL)
|
13.5–17.5
|
13.20
|
10.40 – 15.5
|
1.14
|
0.59
|
|
Bilt (mg/dL)
|
0–1
|
0.65
|
0.20 – 14.6
|
1.31
|
0.02*
|
|
SGOT (mg/dL)
|
10–40
|
37.50
|
17 – 97
|
0.99
|
0.79
|
|
SGPT (mg/dL)
|
10–55
|
28.50
|
12 – 121
|
0.98
|
0.21
|
|
AP (U/L)
|
45–115
|
111.50
|
58 – 434
|
1
|
0.93
|
|
GLU (mg/dL)
|
70–110
|
114
|
69 – 247
|
0.99
|
0.88
|
|
BUN (mg/dL)
|
8–25
|
13.50
|
8 – 25
|
0.96
|
0.51
|
|
Cr (mg/dL)
|
0.60–1.50
|
0.80
|
0.50 – 1.90
|
0.49
|
0.42
|
|
LDH (U/L)
|
110–210
|
196.50
|
69 – 1116
|
0.99
|
0.07
|
|
CA19-9 (U/mL)
|
37
|
360
|
11 – 38000
|
1
|
0.28
|
|
log CA19-9 (U/mL)
|
-
|
2.55
|
1.04 – 4.57
|
1.32
|
0.04*
|
|
log CA19-9 dif (U/mL)
|
-
|
5.81
|
1.38 – 10.50
|
1.15
|
0.34
|
- HCT = hematocrit; Hgb = hemoglobin; Bilt = total bilirubin; SGOT = aspartate transaminase; SGPT = alanine transaminase; AP = Alkaline Phosphatase; GLU = glucose; BUN = Blood Urea Nitrogen; Cr = creatinine; LDH = Lactic dehydrogenase; CA19-9 = tumor marker; log CA19-9 = logarithm of CA19-9; log CA19-9 dif = difference between the logarithm of pre- and post-therapy CA19-9 levels. HR = Hazard ratio for Overall Survival after univariate analysis. P value = level of significance.
